199 related articles for article (PubMed ID: 23384618)
1. Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients.
Huang HJ; Zhang AY; Cao HC; Lu HF; Wang BH; Xie Q; Xu W; Li LJ
Dig Liver Dis; 2013 Aug; 45(8):677-82. PubMed ID: 23384618
[TBL] [Abstract][Full Text] [Related]
2. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
[TBL] [Abstract][Full Text] [Related]
3. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?
Zhao X; Peter A; Fritsche J; Elcnerova M; Fritsche A; Häring HU; Schleicher ED; Xu G; Lehmann R
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E384-93. PubMed ID: 19066319
[TBL] [Abstract][Full Text] [Related]
4. Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis.
Tang YM; Wang JP; Bao WM; Yang JH; Ma LK; Yang J; Chen H; Xu Y; Yang LH; Li W; Zhu YP; Cheng JB
Int J Mol Med; 2015 Aug; 36(2):377-85. PubMed ID: 26046127
[TBL] [Abstract][Full Text] [Related]
5. The potential of nanoflow liquid chromatography-nano electrospray ionisation-mass spectrometry for global profiling the faecal metabolome.
Chetwynd AJ; Ogilvie LA; Nzakizwanayo J; Pazdirek F; Hoch J; Dedi C; Gilbert D; Abdul-Sada A; Jones BV; Hill EM
J Chromatogr A; 2019 Aug; 1600():127-136. PubMed ID: 31047664
[TBL] [Abstract][Full Text] [Related]
6. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
[TBL] [Abstract][Full Text] [Related]
7. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
[TBL] [Abstract][Full Text] [Related]
8. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
Aliwa B; Horvath A; Traub J; Feldbacher N; Habisch H; Fauler G; Madl T; Stadlbauer V
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2676-2691. PubMed ID: 37767786
[TBL] [Abstract][Full Text] [Related]
9. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
[TBL] [Abstract][Full Text] [Related]
10. Metabonomic study on the antitumor effect of flavonoid derivative 3d in HepG2 cells and its action mechanism.
Gao D; Jin F; Liu H; Wang Y; Jiang Y
Talanta; 2014 Jan; 118():382-8. PubMed ID: 24274312
[TBL] [Abstract][Full Text] [Related]
11. Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients.
Wang X; Wang X; Xie G; Zhou M; Yu H; Lin Y; Du G; Luo G; Jia W; Liu P
J Proteome Res; 2012 Jul; 11(7):3838-47. PubMed ID: 22624806
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography-mass spectrometry-based metabolomic analysis of livers from aged rats.
Son N; Hur HJ; Sung MJ; Kim MS; Hwang JT; Park JH; Yang HJ; Kwon DY; Yoon SH; Chung HY; Kim HJ
J Proteome Res; 2012 Apr; 11(4):2551-8. PubMed ID: 22380686
[TBL] [Abstract][Full Text] [Related]
13. Faecal metabolomic fingerprint after moderate consumption of red wine by healthy subjects.
Jiménez-Girón A; Ibáñez C; Cifuentes A; Simó C; Muñoz-González I; Martín-Álvarez PJ; Bartolomé B; Moreno-Arribas MV
J Proteome Res; 2015 Feb; 14(2):897-905. PubMed ID: 25496753
[TBL] [Abstract][Full Text] [Related]
14. Ultra-high performance liquid chromatography tandem mass spectrometry for comprehensive analysis of urinary acylcarnitines.
Zuniga A; Li L
Anal Chim Acta; 2011 Mar; 689(1):77-84. PubMed ID: 21338760
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS).
Kim JY; Park JY; Kim OY; Ham BM; Kim HJ; Kwon DY; Jang Y; Lee JH
J Proteome Res; 2010 Sep; 9(9):4368-75. PubMed ID: 20560578
[TBL] [Abstract][Full Text] [Related]
16. Accurate enzymatic measurement of fecal bile acids in patients with malabsorption.
Porter JL; Fordtran JS; Santa Ana CA; Emmett M; Hagey LR; Macdonald EA; Hofmann AF
J Lab Clin Med; 2003 Jun; 141(6):411-8. PubMed ID: 12819639
[TBL] [Abstract][Full Text] [Related]
17. UPLC-MS-based serum metabonomics for identifying acute liver injury biomarkers in Chinese miniature pigs.
Ma J; Yu J; Su X; Zhu C; Yang X; Sun H; Chen D; Wang Y; Cao H; Lu J
Toxicol Lett; 2014 Mar; 225(3):358-66. PubMed ID: 24451218
[TBL] [Abstract][Full Text] [Related]
18. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program.
Zhang AH; Wang P; Sun H; Yan GL; Han Y; Wang XJ
Mol Biosyst; 2013 Sep; 9(9):2259-65. PubMed ID: 23821129
[TBL] [Abstract][Full Text] [Related]
19. Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis.
Joseloff E; Sha W; Bell SC; Wetmore DR; Lawton KA; Milburn MV; Ryals JA; Guo L; Muhlebach MS
Pediatr Pulmonol; 2014 May; 49(5):463-72. PubMed ID: 23847148
[TBL] [Abstract][Full Text] [Related]
20. Presence of bile acid metabolites in serum, urine, and faeces in cirrhosis.
Jönsson G; Hedenborg G; Wisén O; Norman A
Scand J Clin Lab Invest; 1992 Oct; 52(6):555-64. PubMed ID: 1411266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
